Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC

NCT03417544 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

19

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Metastatic Breast Cancer
Central Nervous System Metastases

Interventions

DRUG: ATEZOLIZUMAB
DRUG: PERTUZUMAB
DRUG: TRASTUZUMAB

Sponsor

Nancy Lin, MD

Collaborators

[object Object]